SCHEMBL3690123

SCHEMBL3690123

CCCCCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PRKCA P17252 10/20 0.52
▸ MAPT P10636 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ LMNA P02545 3/20 0.44
▸ PRKCE Q02156 1/20 0.44
▸ PRKCQ Q04759 1/20 0.44
▸ PRKCD Q05655 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ DUSP3 P51452 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL213208 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL10262394 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL6748385 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL5448 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL1660832 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL24214 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL15665811 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL1356717 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL3834 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE
SCHEMBL15952 1.00 PRKCA (0.52) PRKCAMAPTMAPK1LMNAPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2166837-A1 DRUG COMBINATION FOR THE TREATMENT OF SKIN DISORDERS Prugen, Inc. (US) 2010-03-31 — — EP disclosed
WO-2008156798-A1 DRUG COMBINATION FOR THE TREATMENT OF SKIN DISORDERS PRUGEN, INC. (US) 2008-12-24 — — WO disclosed
EP-1061896-A1 COSMETIC METHOD OF TREATING SKIN UNILEVER PLC (GB) 2000-12-27 — — EP disclosed
US-6042841-A Cosmetic method of treating skin UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) 2000-03-28 — — US disclosed
US-6036963-A COSMETICS FOR SKIN WITH RETINOL, RETINOIC ACID, RETINAL, RETINYL ESTER AND MIXTURES WITH LACTONES AND VEHICLES CHESEBROUGH-PONDS'S USA CO., DIVISION OF CONOPCO, INC. (US) 2000-03-14 — — US disclosed
WO-1999055300-A1 SKIN CARE COSMETIC COMPOSITIONS UNILEVER PLC (GB) 1999-11-04 — — WO disclosed
WO-1999047110-A1 COSMETIC METHOD OF TREATING SKIN UNILEVER PLC (GB) 1999-09-23 — — WO disclosed
WO-1999037281-A1 SKIN CARE COSMETIC METHOD AND SYSTEM UNILEVER PLC (GB) 1999-07-29 — — WO disclosed
US-5744148-A CONTAINING A HYDROXY ACID CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) 1998-04-28 — — US disclosed
Send feedback